Feed aggregator
New blood test predicts illness progression and treatment response
Scientists are developing a test which could one day be used to predict how a patient's illness will progress, and even how well they will respond to treatment.
Blood-based biomarkers identified for early inflammatory breast cancer diagnosis
Researchers at The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have identified specific blood-based genomic biomarkers that distinguish inflammatory breast cancer from other subtypes, providing a new and less invasive method for early diagnosis, disease progression monitoring and treatment development for patients with this aggressive disease.
Using Apple Watch and AI to protect children undergoing cancer treatment from infections
A new trial will test whether a tool that harnesses Apple Watch health data and artificial intelligence can help protect children undergoing cancer treatment from infections.
Testosterone may help limit brain tumor growth in men
In a new National Institutes of Health (NIH)-funded study, scientists at Cleveland Clinic discovered that hormones associated with male development may play a key role in limiting the growth of brain tumors in men.
GLP-1 weight-loss drugs modulate brain reward circuits to suppress eating for pleasure
A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight-loss drugs suppress eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain.
New discovery challenges a decades-old assumption in HIV biology
Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect resting immune cells.
Study challenges long-held assumptions about causes of lacunar stroke
Scientists have uncovered new evidence that challenges long-held assumptions about the causes of a common type of stroke, offering clues as to why widely used treatments may not work.
Bariatric surgery offers greater long-term health protection for seniors than GLP-1 drugs
Metabolic and bariatric surgery offers significantly greater long-term protection against heart attack, stroke and death than widely-used GLP-1 drugs in older adults with obesity and diabetes, according to new real-world analysis study presented today at the annual meeting of the American Society for Metabolic and Bariatric Surgery.
Bariatric surgery outperforms GLP-1 medications for obesity disease remission
Metabolic and bariatric surgery delivers significantly greater weight loss and higher rates of obesity-related disease remission than glucagon-like peptide-1 receptor agonists (GLP-1s), according to one of the largest and most comprehensive real-world comparisons of the two treatments.
Study examines factors associated with co-occurrence of autism and epilepsy in children
Children with epilepsy have a higher risk of also having autism spectrum disorder (ASD). A new study in Developmental Medicine & Child Neurology examined factors associated with the co-occurrence of autism and epilepsy in a large population-based group.
Targeting a parasite-specific enzyme offers new hope for malaria treatment
Research published in The FEBS Journal may help overcome challenges to the treatment of malaria-a tropical disease caused by infection of red blood cells with Plasmodium parasites, which are transmitted through infected mosquito bites.
Daily movement is linked to better mood and emotional well-being
Going on walks, going up stairs, working around the home: One meta-study shows how everyday movements are linked to our mood.
Organic lithium salts may affect many cellular level changes in Alzheimer's disease
Lithium chloride may affect many cellular level changes in Alzheimer's disease, a new study from the University of Eastern Finland (UEF) shows.
New inhibitor design provides a blueprint for effective malaria treatments
Researchers from the Universities of Bath and Leeds (UK) have made a significant advance in the fight against malaria by uncovering a promising new potential target for drug discovery.
USF researchers develop AI framework to predict immune system responses
Artificial intelligence is increasingly being used to help scientists accelerate drug discovery and search for new treatments.
Six genes found to connect pancreatic cancer with metabolic dysfunction
New research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain why people with metabolic disease often face poorer cancer outcomes and pointing to future ways to predict recurrence and develop more targeted treatments.
4basebio announces lease of an innovation hub and manufacturing facility in Cambridge, UK
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces a significant expansion into a new innovation hub and manufacturing facility in Cambridge, UK, supporting growing demand for research and high-quality grade manufacturing of synthetic DNA for gene and cell therapies, mRNA vaccines, genome editing, or DNA vaccines.
Chronic sunlight exposure disrupts body clocks in skin
Years of chronic exposure of human skin to sunlight strongly disrupts its body‑clock rhythm, according to a pioneering study led by University of Manchester, No7 Beauty Company, a member of The Boots Group, and University of Pennsylvania scientists.
Popular GLP-1 drugs significantly reduce major cardiovascular events,
Researchers evaluate the long-term cardiovascular safety and efficacy of GLP-1RAs in high-risk populations.
H5N1 spreads through multiple routes on infected dairy farms
The H5N1 strain of highly pathogenic avian influenza H5N1 has been detected in over 700 herds of dairy cows in California, the largest dairy-producing state in the U.S.




